Technicals Stability Returns

Fundamental Analysis of IOL Chemicals and Pharmaceuticals (IOLCP)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Valuation Ratio    Profitability Ratios    Solvency    Efficiency Ratios    

Guru Numbers
Book Value/Share237.15
EV/EBITDA7.16
Market Cap (Cr)1968.69
Enterprise Value (Cr)1871.45
Piotroski F-Score3.00
Altman Z Score4.71
Graham No330.81
Price/ Graham 1.01
Peter Lynch Ratio-3.81
Sloan Ratio0.099
Peter Lynch Fair value448.35
Price/ Peter Lynch FV0.748
TSR Fair value839.10
Key Financial ratios of IOLCP
Ratio Latest FY Yoy Change TTM MRQ Screener/
About
Price to Earning    12.38 70.26 % 16.35    
Price to Book    1.49 -41.87 % 1.38 1.37    
Price to Sales    0.951 -41.80 % 0.881    
Earning Per Share    28.56 -62.29 % 20.51 2.71    
Return On Equity    12.04 -65.86 % 8.70 1.10    
Return On Asset    8.54 -69.05 % 6.36 0.791    
Net Profit Margin    7.68 -66.03 % 5.39 2.94    
Operating Profit Margin    9.21 -67.26 % 7.11 5.89    
EBITDA Margin    12.66 -59.27 % 9.76 6.83    
Debt to Equity Ratio    0.0307 4200.17 % 0.061    
Current Ratio    2.11 -40.17 % 1.91    
Quick Ratio    1.31 -47.78 % 1.23    
View Historitcal ratios of IOL Chemicals and Pharmaceuticals
Valuation Ratios   Profitability Ratio   Solvency Ratios   Efficiency Ratios
Screen Financial Ratio using Custom Screener
Terrific View
Tsr Value Index - Good Score of 70.83
Tsr Growth Index - Good Score of 68.25
Tsr Stability Index - Excellent Score of 90.62
Altman Z Score of 4.71 suggests good Stability
Undervalued - Price to Intrinsic Value of 0.400
Earning Yield of 8.52 %
Tremendous increasing in Book Value last 3 year
Steady View
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Good Return On Capital Employed of 11.68
Risky View
Tsr Profitability Index - Very Poor Score of 15.00
Stock Returns < -26.00 % Than Nifty in last one year
Current price is less than One year old price and One Year old price is less then two year old price
Operating Cash Flow decreasing for last 3 year
Company is unable to generate enough free cash to support the business.
EPS decline for last four quarters
Terrific Steady Risky Stock View - Fundamental Snapshot
Share Overview
Promoter Owned43.70 %
Institution Owned2.50 %
Public/Others53.80 %
Outstanding Shares5.87 Cr
Floating Shares2.10 Cr
Floating / Outstanding35.78%
Book Value/Share237.15
Face value10.00
Share Holding
Annual Key Income Statement of IOLCP
Period 31_Mar_2022 31_Mar_2021 Growth
Net Income From Continuing Ops 167.67 444.56 62.28 %
Net Income 167.67 444.56 62.28 %
Operating Income 201.10 553.14 63.64 %
Total Revenue 2184.02 1966.98 11.03 %
Operating Expense 1977.28 1419.89 39.26 %
Interest Expense 8.29 5.83 42.20 %
Tax Expense 57.18 126.83 54.92 %
Income Before tax 224.85 571.39 60.65 %
Gross Profit 613.51 821.97 25.36 %
Dividend Paid -35.22 -23.48 50.00 %
   
Quarterly Key Income Statement of IOLCP
Period 30_Sep_2022 30_Jun_2022 Growth
Net Income From Continuing Ops 15.91 34.67 54.11 %
Net Income 15.91 34.67 54.11 %
Operating Income 31.90 44.81 28.81 %
Total Revenue 541.41 565.01 4.18 %
Operating Expense 509.51 520.20 2.05 %
Interest Expense 3.51 3.38 3.85 %
Tax Expense 6.23 11.92 47.73 %
Income Before tax 22.14 46.59 52.48 %
Gross Profit 138.65 170.46 18.66 %
Dividend Paid 0 0 %
   
Key Balance Sheet Fields
Period 31_Mar_2022 31-Mar-21 Growth
Common Stock 58.71 58.71 0 %
Current Liabilities 513.40 290.55 76.70 %
Total Liabilities 570.02 349.66 63.02 %
Current Assets 1080.82 1022.29 5.73 %
Total Assets 1962.30 1610.09 21.88 %
Working capital 567.42 731.74 22.46 %
Accounts Payable 409.29 238.83 71.37 %
Inventory 409.89 295.15 38.88 %
Net Receivable 469.80 300.31 56.44 %
   
Key Cash Flow Fields
Period 31_Mar_2022 31_Mar_2021 Growth
Cash EPS 35.91 82.89 56.68 %
Cash From Investment Activity -120.19 -317.25 62.12 %
Cash From Financial Activity -1.64 -58.28 97.19 %
Cash Operational Activity 93.05 379.78 75.50 %
Net Cash Flow -28.78 4.25 777.18 %
NetIncome 167.67 444.56 62.28 %
Capital Expenditure 153.29 108.21 41.66 %
Change To Inventory -114.75 -107.62 6.63 %
   



   About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. Its products are used for treatments, which include anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-cholelithic, as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana, India.

Address : 85, Industrial Area 'A', Ludhiana, India, 141003

URL : https://www.iolcp.com

Employee Count : 2316

About TSR TECH Strength / Valuation / Growth

TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick

TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential

TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value

This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.